Twist Bioscience Corporation
Twist Bioscience uses a proprietary silicon-based DNA writing platform across drug discovery, diagnostics, agriculture and industrial materials. Revenue increased 23% year over…
TWST
4 published ideas on Twist Bioscience Corporation across 2 funds — 4 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Twist Bioscience Corporation: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Twist Bioscience uses a proprietary silicon-based DNA writing platform across drug discovery, diagnostics, agriculture and industrial materials. Revenue increased 23% year over…
Twist Bioscience operates a proprietary silicon-based DNA writing platform serving synthetic biology applications across drug discovery, diagnostics, agriculture and industrial…
Twist Bioscience operates a proprietary silicon-based DNA writing platform serving synthetic biology applications across drug discovery, diagnostics, agriculture and industrial…
Twist Bioscience uses a proprietary silicon-based DNA writing platform across drug discovery, diagnostics, agriculture and industrial materials. Revenue increased 23% year over…